Dr. Peter Fedichev, Ph.D. is the CEO of Gero (https://gero.ai/), a biotech company focused on hacking complex diseases, including aging, with AI for novel drug discovery, as well as digital biomarkers.
Gero’s models originate from the physics of complex dynamic systems, combining the potential of deep neural networks with the physical models to study dynamical processes and understand what drives diseases.
Dr. Fedichev has a background in biophysics, bioinformatics and condensed matter physics, earning his Ph.D. from the University of Amsterdam, and he conducted research at FOM Institute AMOLF (part of the institutes organization of the Dutch Research Council of Netherlands) and the University of Innsbruck.
To date, Dr Fedichev has published over 70 papers covering his research on physics, biophysics and aging biology.
Comments are closed.